skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Infliximab (Remicade) in the treatment of psoriatic arthritis

(2306) Views  (560) Full article downloads

Authors: Philip Mease

Published Date January 2006 Volume 2006:2(4) Pages 389 - 400
DOI: http://dx.doi.org/10.2147/TCRM.S

Philip Mease

Seattle Rheumatology Associates, Division of Rheumatology Research, Swedish Medical Center, University of Washington School of Medicine, Seattle, WA, USA

Abstract: Elucidation of the cellular immunopathology and cytokine profile of psoriatic arthritis (PsA), a chronic inflammatory disease associated with psoriasis, has resulted in the development of a number of novel biologic therapies. Among these biologics, tumor necrosis factor-alpha (TNF-á) inhibitors have been used successfully to treat patients suffering from rheumatoid arthritis or psoriasis. The pivotal role of TNF-á in the pathogenesis and progression of PsA suggested that anti-TNF-á agents could be effective in controlling PsA. The results from two large, randomized, double-blind, placebo-controlled trials in patients with moderate to severe PsA indicated that the anti-TNF- inhibitor, infliximab, can control both the joint and skin manifestations of the disease. This review focuses on the clinical development of infliximab as a treatment for PsA. The development of other anti-TNF-á biologics is also discussed.

Keywords: psoriatic arthritis, psoriasis, spondyloarthropathies, TNF inhibition, biologics








Readers of this article also read:

Drug focus: adalimumab in the treatment of moderate to severe psoriasis
Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease
Effectiveness of lifestyle measures in the treatment of gastroesophageal reflux disease – a case series
Brimonidine in the treatment of glaucoma and ocular hypertension
In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technologic advancement
Abatacept in the treatment of rheumatoid arthritis
Moxifloxacin in the treatment of skin and skin structure infections
The safety of etanercept for the treatment of plaque psoriasis
Current approach to cancer pain management: Availability and implications of different treatment options
Detection and remediation of medically urgent situations using telemedicine case management for older patients with diabetes mellitus